default author photo

Marcello Tiseo

University Hospital of Parma

SCHOLARLY PAPERS

3

DOWNLOADS

84

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Liquid Biopsy and 18f-Fdg Pet/Ct Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced Egfr-Mutated Nsclc

Number of pages: 26 Posted: 03 Jun 2024
University Hospital of Parma, University Hospital of Parma, University Hospital of Parma, University Hospital of Parma, University Hospital of Parma, University of Parma, University Hospital of Parma, University Hospital of Parma, University Hospital of Parma, University Hospital of Parma, University Hospital of Parma, University Hospital of Parma, University Hospital of Parma, University Hospital of Parma and University Hospital of Parma
Downloads 31 (1,332,057)

Abstract:

Loading...

NSCLC, EGFR activating mutation, osimertinib, predictive factors, Liquid biopsy, 18F-FDG PET/CT

2.

Locally Advanced Nsclc: Overview of Real-World Pattern of Recurrence in Durvalumab Era (Leopard Trial)

Number of pages: 17 Posted: 05 Jun 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University Hospital of Parma, affiliation not provided to SSRN, University Hospital of Parma, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Florence, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Ospedale Sacro Cuore Don Calabria, affiliation not provided to SSRN, University Hospital of Parma, affiliation not provided to SSRN, affiliation not provided to SSRN, Oncology Institute of Southern Switzerland and affiliation not provided to SSRN
Downloads 29 (1,359,097)

Abstract:

Loading...

non-small cell lung cancer, radiotherapy, durvalumab, oligorecurrence, recurrence pattern, chemoradiotherapy, salvage therapy, SBRT, PACIFICnon-small cell lung cancer, radiotherapy, durvalumab, oligorecurrence, recurrence pattern, chemoradiotherapy

3.

The biomarkers ATLAS knowledge-based database: a two-year challenge updates for non-small cell lung cancer patients

Number of pages: 29 Posted: 28 Apr 2026
University of Naples Federico II, “Vito Fazzi” Hospital, University of Turin, University of Naples Federico II, University of Milano-Bicocca - Fondazione IRCCS San Gerardo dei Tintori, University of Padua - Department of Medicine, University of Naples Federico II, affiliation not provided to SSRN, University of Turin, affiliation not provided to SSRN, University of Milano-Bicocca, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Naples Federico II, University of Verona, University Hospital of Parma, Università degli Studi di Genova, University of Turin, affiliation not provided to SSRN, University of Florence, affiliation not provided to SSRN, Ospedale Giovanni Paolo II, affiliation not provided to SSRN, affiliation not provided to SSRN, Università Vita-Salute San Raffaele - San Raffaele Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Naples Federico II - Department of Public Health, University of Turin and University of Naples Federico II
Downloads 24 (1,411,822)

Abstract:

Loading...

database, molecular records, clinical records, NSCLC